Clover Corporation Ltd has released a press release.
N3RO Clinical Research Study - Initial Results
Filed with ASX ·
Watch Clover's latest callClover (ASX:CLV) Q4 2026 Earnings Call · Replay · Sep 22Read the transcript of Clover (ASX:CLV) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Clover Corporation Limited on 6ix
Earlier from Clover
- New Encapsulation Reseach Program
- Chairman`s Address to Shareholders
- Clover achieves GRAS status for Pre-term Emulsion
- Impairment and Divestment of Future Food Ingredients
- 3 Year Global Supply Agreement
Later from Clover
- Clover 1H17 Results - improved net profit
- Response to ASX Price Query
- Clarification of ex dividend date
- Clover adds spray drying capacity with investment
- S&P DJI Announces March 2019 Quarterly Rebalance
Follow Clover into a list and get an email when it puts out news.
Follow Clover